Fuan Pharmaceutical (Group) Co., Ltd. (SHE:300194)
China flag China · Delayed Price · Currency is CNY
3.530
-0.070 (-1.94%)
Nov 13, 2026, 3:04 PM CST

SHE:300194 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Revenue
1,6481,7382,3912,6482,4222,453
Revenue Growth
-3.74%-27.31%-9.68%9.33%-1.28%3.58%
Gross Profit
609.97607.611,2181,3671,3551,517
Operating Income
101.4556.69248.55184.51100.24147.59
Net Income
34.7577279.84231.87204.61-296.91
Earnings Per Share
0.030.060.240.190.17-0.25
EPS Growth
-79.06%-75.00%26.32%11.77%--

Revenue by Geography

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Dec '23 Jan '23 Jan '22
Northeast China
28.1967.3889.41108.46152.74
Northern china
157.75239.43318.08279.12278.85
East China
655.96849.47851.69753.57749.9
Southern China
130.63192.55214.83207.11213.96
Central China
348.56487.81459.93434.04364.81
Northwestern Region
52.2674.2680.73195.3374.34
Southwest Region
227.73330.52477.85274.6389.09
Export and Others
77.0466.9578.28125.3164.76
Unallocated
60.1783.176.9444.2264.71
Total
1,7382,3912,6482,4222,453

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Investments
807.141,037876.32996.89703.741,002
Total Debt
542.22800.42705.78892.86714.2906.03
Net Cash (Debt)
264.92236.24170.54104.03-10.4595.96
Net Cash Growth
58.34%38.52%63.93%---68.79%
Net Cash Per Share
0.200.180.150.09-0.010.08

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Cash Flow
375.43312.32303.59328.98339.5257.13
Capital Expenditures
-101.28-108.43-241.79-215.68-383.1-413.03
Free Cash Flow
274.15203.8961.8113.3-43.6-155.91
Free Cash Flow Growth
-229.94%-45.46%---

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Gross Margin
37.02%34.96%50.91%51.63%55.97%61.85%
Operating Margin
6.16%3.26%10.39%6.97%4.14%6.02%
Pretax Margin
3.12%4.79%13.05%10.97%7.82%-24.13%
Profit Margin
2.11%4.43%11.70%8.76%8.45%-12.10%
FCF Margin
16.64%11.73%2.58%4.28%-1.80%-6.35%

Dividends

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Jan '23
Dividend Per Share
0.0700.0700.0500.0500.050
Dividend Per Share Growth
40.00%40.00%0%0%-
Dividend Yield
1.98%1.58%1.12%1.14%1.39%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
PE Ratio
134.3868.4518.9622.4720.93-
Forward PE
-95.5595.5595.5595.5595.55
P/FCF Ratio
15.5425.8585.8745.99--
PS Ratio
2.593.032.221.971.772.48